Exciting news has emerged from the biotech sector as Outrun Therapeutics, a pioneering company focused on leveraging protein stabilisation through E3 Ligase inhibition to combat cancer and other illnesses, recently announced a successful funding round, raking in an impressive $10,000,000. With a firm commitment to revolutionizing treatment options, the company plans to utilize this substantial influx of capital to further advance their cutting-edge research and development efforts. This latest funding milestone underscores Outrun Therapeutics' dedication to pushing the boundaries of medical innovation and underscores investor confidence in the company's potential to make a tangible impact in the fight against complex diseases. With their groundbreaking approach to leveraging protein stabilisation, Outrun Therapeutics is poised to make significant strides in improving patient outcomes and reshaping the landscape of modern healthcare.
Outrun Therapeutics Secures $10 Million in Seed Funding to Revolutionize Protein Stabilisation for Cancer Treatment
Recently funded 路 $10.0M SeedBiotechnology
Get the full Outrun Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Seed rounds
Companies that recently closed a Seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  DIMENSION United States | Seed | $1.6M | today |
| 2 |  Dimension Studios United States | Seed | $1.6M | today |
